CORDIS · 853989 · H2020
ERA4TB EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS
Coordinator: UNIVERSIDAD CARLOS III DE MADRID (ES)
The European Regimen Accelerator for Tuberculosis (ERA4TB) has the explicit goal of developing a new combination therapy to treat all forms of TB starting from ~20 leads and drug candidates provided by EFPIA. Since details of these are as yet unavailable, we will implement an agile drug development algorithm that entails profiling and portfolio construction. Profiling involves characterisation and ranking molecules in preclinical studies comprising in vitro drug combination assays, hollow fiber and single cell analysis, innovative murine and non-human primate models, PK/PD studies, combined w…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
Co-funding: the European Union contributes €89.8M toward a total project budget of €208.0M — a funding rate of 43%, with the remainder covered by the consortium partners. The project runs over approximately 7 years from 2020-01-01 to 2026-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from ES
see all →- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · HORIZON · €206.9M
- DRIVER+ — DRiving InnoVation in crisis management for European Resilience607798 · FP7 · €33.5M
- READI — Research in Europe and Diversity Inclusion101166227 · HORIZON · €31.5M
- GREENH2ATLANTIC — A 100 MW FLEXIBLE GREEN HYDROGEN PRODUCTION PROCESS SOURCING HYBRID RENEWABLE ENERGY AND SUPPLYING GREEN HYDROGEN TO MULTIPLE END-USES101036908 · H2020 · €30.0M
- PERSEUS — Protection of European seas and borders through the intelligent use of surveillance261748 · FP7 · €27.8M
- HE23-24 TOP4 — SST Sensors and Processing. Horizon Europe TOP4101242896 · HORIZON · €27.5M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- HBP SGA1 — Human Brain Project Specific Grant Agreement 1720270 · CH · €89.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the RIA funding scheme.
- What is the EU contribution?
- The European Commission contributes €89.8M toward a total project budget of €208.0M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-JTI-IMI2-2018-15-two-stage.
- Who coordinates the project?
- The project is coordinated by UNIVERSIDAD CARLOS III DE MADRID (ES).
- What is the project timeline?
- The project runs from 2020-01-01 to 2026-12-31 — approximately 7 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 853989.